Nicholas Shorts

Nicholas leads the Pharma column. He is an excellent writer and a team leader with five years’ experience in medical writing. Nicholas is a Journalism degree holder from Texas A&M University. Before taking up Medical literature, he was a Journalism professor. Nicholas is also a poet.

Pharma

Nicholas Shorts July 24, 2019 7:00 AM EST
0 333

MVASI™ (bevacizumab-awwb) and KANJINTITM (trastuzumab-anns) Now Available in US

Amgen and Allergan plc proposed that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin®…
Read More »
News

Nicholas Shorts July 23, 2019 4:40 AM EST
0 285

FDA Authorized Multiple Applications for First Generics of Lyrica

U.S. Food and Drug Administration authorized multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain…
Read More »
News

Nicholas Shorts July 19, 2019 5:10 AM EST
0 286

Boehringer Ingelheim to Purchase All Shares of AMAL Therapeutics SA to Concentrate On Novel Cancer Vaccine

Boehringer Ingelheim announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company concentrate on cancer…
Read More »
News

Nicholas Shorts July 12, 2019 3:12 AM EST
0 141

Novartis, Amgen, And Banner Alzheimer’s Institute Announced Discontinuation Investigation of The BACE1 Inhibitor CNP520 for Alzheimer’s Prevention

Novartis, Amgen, and Banner Alzheimer’s Institute announced that they would discontinue the investigation of the BACE1 inhibitor CNP520 (umibecestat) in…
Read More »
Pharma

Nicholas Shorts July 11, 2019 2:56 AM EST
0 153

FDA to Review BLA for Isatuximab to Treat RRMM

The FDA has accepted for an overview of the Biologics License Application (BLA) for isatuximab for the therapy of patients…
Read More »
News

Nicholas Shorts July 10, 2019 5:06 AM EST
0 181

NHS Plans to Test a First-Of-Its-Kind ‘Subscription-Style’ Payment

The Government has introduced further particulars for how they plan to support pharmaceutical companies’ investments within the development of medicines to…
Read More »
Pharma

Nicholas Shorts July 8, 2019 3:02 AM EST
0 134

Pfizer Inc. Successfully Completed Acquisition of the Therachon

Pfizer Inc. introduced the successful completion of its acquisition of the privately-held clinical-stage biotechnology firm Therachon Holding AG. Under the…
Read More »
News

Nicholas Shorts July 5, 2019 5:01 AM EST
0 150

FDA Has Approved Xpovio for Multiple Myeloma

The US Food and Drug Administration granted sped up approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone…
Read More »
Pharma

Nicholas Shorts July 4, 2019 4:28 AM EST
0 155

Bayer’s Global Prescription Dermatology Transfers to LEO Pharma

LEO Pharma and Bayer introduced at this time the achievement of the relevant closing circumstances to permit the transmission of…
Read More »
Medicine

Nicholas Shorts July 3, 2019 3:30 AM EST
0 125

Researchers One Step Closer to Find Cure for HIV – Using Combination of CRISPR and LASER ART Eliminated HIV DNA from Live Mice

Researchers say they’re one step closer to discovering a possible cure for HIV after successfully eliminating the virus in live…
Read More »